Sponsor Pipeline

Canwell Biotech Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07664150 CW-301 FIH Study of CAN016 Patients With Advanced Solid Tumors Recruiting
Phase 1
NCT06332430 Intratumoral CAN2109 in Subjects With Solid Tumors Solid Tumor Recruiting
NCT05580991 Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors Solid Tumor Active, Not Recruiting
Get alerts when Canwell Biotech Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free